MétaCan
Menu
Back to cohort
Record W4410796228 · doi:10.1053/j.gastro.2025.05.015

An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease

2025· article· en· W4410796228 on OpenAlexaff
Jurij Hanžel, Virginia Solitano, Sudheer K. Vuyyuru, Remo Panaccione, Bruce E. Sands, Laurent Peyrin‐Biroulet, Silvio Danese, Geert D’Haens, Raja Atreya, Matthieu Allez, Çharles N. Bernstein, Peter Bossuyt, Brian Bressler, Robert V. Bryant, Benjamin L. Cohen, Jean–Frédéric Colombel, Ferdinando D’Amico, Axel Dignaß, Marla Dubinsky, Phillip Fleshner, Richard B. Gearry, Stephen B. Hanauer, Ailsa Hart, Maia Kayal, Torsten Kucharzik, Péter L. Lakatos, Édouard Louis, Fernando Magro, Neeraj Narula, Rupert W. Leong, Julián Panés, Tim Raine, Zhihua Ran, Miguel Regueiro, Walter Reinisch, Siddharth Singh, A. Hillary Steinhart, Simon Travis, Ryan C. Ungaro, C. Janneke van der Woude, Takayuki Yamamoto, Vineet Ahuja, David T. Rubin, Parambir S. Dulai, Linda J. Cornfield, Malcolm Hogan, William J. Sandborn, Brian G. Feagan, Vipul Jairath, Christopher Ma

Bibliographic record

VenueGastroenterology · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsMcMaster UniversityPopulation Health Research InstituteMcGill UniversityMcGill University Health CentreUniversity of British ColumbiaHealth Sciences CentreUniversity of ManitobaMontreal General HospitalManitoba HealthMount Sinai HospitalUniversity of CalgaryWestern University
FundersU.S. National Library of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases
KeywordsInflammatory bowel diseaseMedicineIntensive care medicineClinical trialDiseaseInflammatory Bowel DiseasesGastroenterologyInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND & AIMS: Approval of new therapies for inflammatory bowel disease (IBD) requires rigorously designed and well-executed randomized controlled trials (RCTs). Corticosteroids remain a cornerstone of IBD induction therapy, and many patients in trials are enrolled while taking corticosteroids. Despite this, approaches to corticosteroid management in RCTs have been highly heterogeneous, often differing from clinical practice. This negatively impacts patients' willingness to participate due to prolonged corticosteroid exposure and may potentially bias outcomes in the clinical trial. Our aim is to provide comprehensive standardized recommendations on key aspects of corticosteroid use in IBD clinical trials through a multiphase, international expert consensus, with a goal to help inform and standardize practice in future RCTs. METHODS: The consensus was informed by a systematic review of MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials, which determined the corticosteroid management rules used in placebo-controlled trials of advanced therapies in IBD. International expert consensus recommendations for all aspects of corticosteroid management in RCTs were then developed using a modified Delphi process with 2 rounds of survey questions and a ratification meeting. RESULTS: These recommendations propose management of corticosteroids during screening, induction, and maintenance phases of pharmacologic trials in IBD and define corticosteroid-related end points. We emphasize the need for minimizing corticosteroid exposure through expedited tapering and shorter fixed-dosing periods that more closely reflect clinical care and provide recommendations for standardized definitions of corticosteroid-free remission. CONCLUSIONS: These recommendations will serve to optimize trial design and facilitate appropriate, acceptable, and standardized RCT corticosteroid handling practices.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.532
metaresearch head score (Gemma)0.554
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.468
Threshold uncertainty score0.577

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.5320.554
Meta-epidemiology (narrow)0.0030.004
Meta-epidemiology (broad)0.0080.016
Bibliometrics0.0170.014
Science and technology studies0.0060.012
Scholarly communication0.0160.013
Open science0.0180.021
Research integrity0.0320.037
Insufficient payload (model declined to judge)0.0040.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.346
Teacher spread0.325 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designNot applicable
DomainMethods
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueGastroenterologySame topicInflammatory Bowel DiseaseFrench-language works237,207